Serodus receives approval of clinical trial application for SER150 in diabetic nephropathy
Monday, June 15, 2015
Serodus ASA :
Receives approval for a clinical trial application from the German Federal Institute for Drugs and Medical Devices (BfArM) to commence a phase IIa safety study with SER150 in patients diagnosed with diabetic nephropathy
Says study will be running during 2015 and 2016
Says expects interim safety results from first cohort end 2015 and final data second half of 2016
reuters.com
